Live Chart
O 23
H 23
L 23
VOL 75
Brawn Biotech Overview
Days Range
Previous Close
₹23.00
Open
₹23.00
Volume
215
Day’s Range
₹23.00 - ₹23.00
52W Range
₹14.36 - ₹24.84
Market Cap
₹6.9 Cr
Fundamentals of Brawn Biotech
| ROCE (TTM) | NA |
| P/E Ratio (TTM) | 37.1 |
| P/B Ratio | 2.3 |
| Industry P/E | 46.65 |
| Debt to Equity | NA |
| ROE | NA |
| EPS (TTM) | 0.62 |
| Dividend Yield | NA |
| Book Value | 10 |
| Face Value | 10 |
Financials of Brawn Biotech
| Jun 2022 | Mar 2023 | Jun 2023 | |
|---|---|---|---|
| Net Sales | 0.12 | 0.12 | 0.12 |
| Expenses | 0.09 | 0.09 | 0.16 |
| Profit before tax | 0.03 | 0.26 | -0.04 |
| Operating Profit | 0.02 | 0.23 | -0.04 |
| Net Profit | 0.02 | 0.23 | -0.04 |
| EPS in Rs | 0.05 | 0.47 | -0.08 |
About Brawn Biotech
BRAWN, with its inception barely 26 years back (1985) has today evolved into a fully integrated, healthcare group, marking its presence in India and dotting various major markets across the globe. BRA ... Read More
Parent Organisation
Indian Private
Founded
1985
Managing Director
NA
NSE Symbol
NA
Peer Comparison
| Stocks | Market Cap (cr) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Oswal Agro Mills Ltd | ₹476.52 |
35.5 0.65 (1.87%) |
34.85 - 36.4 |
| Standard Industries Ltd | ₹147.76 |
22.7 0.15 (-0.66%) |
22.55 - 23.25 |
| Ashoka Metcast Ltd | ₹46.59 |
18.75 0.65 (3.59%) |
17.6 - 18.8 |
| Kalyani Commercials Ltd | ₹11.93 |
119.3 0.00 (0.00) |
119.3 - 119.3 |
| J D Orgochem Ltd | ₹7.09 |
3.4 0.00 (0.00) |
3.4 - 3.4 |
What's Trending
FAQs
What is the Share price of Brawn Biotech ()?
Brawn Biotech () share price as of September 25, 2023, on BSE is Rs 23.00 (BSE).
Can I buy Brawn Biotech () shares?
Yes, You can buy Brawn Biotech () shares by opening a Demat account with Angel One.
How do I buy Brawn Biotech () from Angel One?
Brawn Biotech () share can be brought through the following modes:
- Direct investment: You can buy Brawn Biotech () shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Brawn Biotech () shares.
